• 11259 Citations
  • 47 h-Index
19942018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
gemcitabine Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2018

  • 11259 Citations
  • 47 h-Index
  • 205 Article
  • 5 Review article
  • 2 Letter
  • 1 Comment/debate

18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study

Taralli, S., Sollini, M., Milella, M., Perotti, G., Filice, A., Menga, M., Versari, A. & Rufini, V., Jan 1 2018, In : EJNMMI Research. 8, 64.

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Somatostatin
Glucose
Somatostatin Receptors
Precision Medicine
4 Citations

A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study

Barone, M., Iannone, A., Shahini, E., Ippolito, A. M., Brancaccio, G., Morisco, F., Milella, M., Messina, V., Smedile, A., Conti, F., Gatti, P., Santantonio, T., Tundo, P., Lauletta, G., Napoli, N., Masetti, C., Termite, A. P., Francavilla, R., Di Leo, A., Pesce, F. & 1 othersAndriulli, A., Jan 1 2018, In : Journal of Viral Hepatitis. 25, 1, p. 56-62 7 p.

Research output: Contribution to journalArticle

Fibrosis
Genotype
Ribavirin
Therapeutics
sofosbuvir drug combination ledipasvir
gemcitabine
Paclitaxel
Pancreatic Neoplasms
Cost-Benefit Analysis
Albumins
Birth Rate
Spontaneous Abortion
Research Personnel
Manuscripts
Names

Do immune checkpoint inhibitors need new studies methodology?

Ferrara, R., Pilotto, S., Caccese, M., Grizzi, G., Sperduti, I., Giannarelli, D., Milella, M., Besse, B., Tortora, G. & Bria, E., May 1 2018, In : Journal of Thoracic Disease. 10, p. S1564-S1580

Research output: Contribution to journalReview article

Clinical Trials
Immunotherapy
Biomarkers
Survival
Proportional Hazards Models